From: Chikungunya seroprevalence in population-based studies: a systematic review and meta-analysis
Region | N of studies | Seroprevalence | 95% CI | I2 (%)* |
---|---|---|---|---|
African | 4 | 31 | 21–41 | 99.43 |
Americas | 15 | 29 | 19–39 | 99.68 |
Eastern Mediterranean | 6 | 5 | 1–10 | 96.21 |
European | 4 | 5 | 0–17 | 99.88 |
South-East Asian | 7 | 24 | 19–29 | 99.73 |
Western Pacific | 15 | 18 | 7–32 | 99.78 |